Drug-resistant bacteria are "a hidden epidemic"

01/22/2013 | Philadelphia Inquirer, The

Bacteria are quickly becoming resistant to known antibiotics, and few new drugs are being developed to fill the void, experts say. Antibiotics are not as profitable for drugmakers as drugs to treat chronic diseases, so the federal government should develop a system to reward discovery and development of new antibiotics, says infectious disease specialist Jeffrey Jacobson.

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY